These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37035895)

  • 1. ASHP commission examines data-driven healthcare.
    Traynor K
    Am J Health Syst Pharm; 2023 May; 80(10):541. PubMed ID: 37035895
    [No Abstract]   [Full Text] [Related]  

  • 2. Executive summary of the meeting of the 2020 ashp Commission on goals: preparing the healthcare workforce for a digital future.
    Am J Health Syst Pharm; 2021 Feb; 78(5):447-453. PubMed ID: 33289015
    [No Abstract]   [Full Text] [Related]  

  • 3. ASHP Health-System Pharmacy 2015 Initiative.
    Myers CE
    Am J Health Syst Pharm; 2004 Apr; 61(7):657. PubMed ID: 15119570
    [No Abstract]   [Full Text] [Related]  

  • 4. Summary of the ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.
    Am J Hosp Pharm; 1992 Mar; 49(3):652-4. PubMed ID: 1598949
    [No Abstract]   [Full Text] [Related]  

  • 5. ASHP therapeutic guidelines on nonsurgical antimicrobial prophylaxis. ASHP Commission on Therapeutics.
    Clin Pharm; 1990 Jun; 9(6):423-45. PubMed ID: 2194737
    [No Abstract]   [Full Text] [Related]  

  • 6. ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. This official ASHP practice standard was developed through the ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 16, 1996.
    Am J Health Syst Pharm; 1997 Feb; 54(3):299-313. PubMed ID: 9028424
    [No Abstract]   [Full Text] [Related]  

  • 7. ASHP guidelines on medication cost management strategies for hospitals and health systems.
    ASHP Expert Panel on Medication Cost Management
    Am J Health Syst Pharm; 2008 Jul; 65(14):1368-84. PubMed ID: 18593684
    [No Abstract]   [Full Text] [Related]  

  • 8. Proposal to change ASHP's name to the American Society of Health-System Pharmacists. ASHP Board of Directors.
    Am J Hosp Pharm; 1994 May; 51(9):1208-11. PubMed ID: 8042641
    [No Abstract]   [Full Text] [Related]  

  • 9. ASHP-PPAG Guidelines for Providing Pediatric Pharmacy Services in Hospitals and Health Systems.
    Eiland LS; Benner K; Gumpper KF; Heigham MK; Meyers R; Pham K; Potts AL
    Am J Health Syst Pharm; 2018 Aug; 75(15):1151-1165. PubMed ID: 29555640
    [No Abstract]   [Full Text] [Related]  

  • 10. Current information on the use of immunobiologics: comments of the ASHP Commission on Therapeutics.
    Lipman AG
    Clin Pharm; 1989 Dec; 8(12):850-1. PubMed ID: 2598609
    [No Abstract]   [Full Text] [Related]  

  • 11. Technology-enabled practice: a vision statement by the ASHP Section of Pharmacy Informatics and Technology.
    ASHP Section of Pharmacy Informatics and Technology Executive Committee, 2008-09
    Am J Health Syst Pharm; 2009 Sep; 66(17):1573-7. PubMed ID: 19710443
    [No Abstract]   [Full Text] [Related]  

  • 12. ASHP therapeutic position statement on the identification and treatment of Helicobacter pylori-associated peptic ulcer disease in adults. Developed by the ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 11, 2000.
    ASHP Commission on Therapeutics. ASHP Board of Directors
    Am J Health Syst Pharm; 2001 Feb; 58(4):331-7. PubMed ID: 11225171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASHP guidelines on the pharmacist's role in home care. Developed through the ASHP Council on Professional Affairs with the assistance of the Executive Committee and Professional Practice Committee of the ASHP Section of Home Care Practitioners and approved by the ASHP Board of Directors on April 27, 2000.
    Am J Health Syst Pharm; 2000 Jul; 57(13):1252-7. PubMed ID: 10902068
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of ASHP therapeutic guidelines.
    Dotson LR; Witmer DR
    Am J Health Syst Pharm; 1995 Feb; 52(3):254-5. PubMed ID: 7749951
    [No Abstract]   [Full Text] [Related]  

  • 15. Executive summary--APhA commission on third party programs.
    Am Pharm; 1986 Apr; NS26(4):49-58. PubMed ID: 3706128
    [No Abstract]   [Full Text] [Related]  

  • 16. ASHP at 75 Years: Celebrating the past and embracing the future.
    Abramowitz PW; Thompson KK; Cobaugh DJ
    Am J Health Syst Pharm; 2017 Dec; 74(23):1936-1937. PubMed ID: 29167133
    [No Abstract]   [Full Text] [Related]  

  • 17. Summary of the ASHP therapeutic guidelines on nonsurgical antimicrobial prophylaxis. ASHP Commission on Therapeutics.
    Am J Hosp Pharm; 1990 Jul; 47(7):1618-21. PubMed ID: 2114793
    [No Abstract]   [Full Text] [Related]  

  • 18. ASHP policy-development process: opportunities for improvement. ASHP Ad Hoc Committee on Policy Development.
    Am J Health Syst Pharm; 1998 May; 55(10):1044-9. PubMed ID: 9606458
    [No Abstract]   [Full Text] [Related]  

  • 19. Report of the study commission on pharmacy.
    Drug Intell Clin Pharm; 1976 Feb; 10(2):119-20. PubMed ID: 10236232
    [No Abstract]   [Full Text] [Related]  

  • 20. ASHP long-range vision for the pharmacy work force in hospitals and health systems: ensuring the best use of medicines in hospitals and health systems.
    Am J Health Syst Pharm; 2007 Jun; 64(12):1320-30. PubMed ID: 17582918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.